ArticleNaunyn-Schmiedeberg's archives of pharmacology2017

Cannabinoid receptor agonist WIN55,212-2 and fatty acid amide hydrolase inhibitor URB597 ameliorate neuroinflammatory responses in chronic cerebral hypoperfusion model by blocking NF-κB pathways.

Shao-Hua Su et al.PubMed ↗Publisher ↗

No numbers read from the abstract.